000 | 00999 a2200289 4500 | ||
---|---|---|---|
005 | 20250518020225.0 | ||
264 | 0 | _c20191118 | |
008 | 201911s 0 0 eng d | ||
022 | _a2374-2445 | ||
024 | 7 |
_a10.1001/jamaoncol.2018.6504 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPashayan, Nora | |
245 | 0 | 0 |
_aOverestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom-Reply. _h[electronic resource] |
260 |
_bJAMA oncology _c03 2019 |
||
300 |
_a428-429 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Comment | ||
650 | 0 | 4 | _aBreast Neoplasms |
650 | 0 | 4 | _aCost-Benefit Analysis |
650 | 0 | 4 | _aEarly Detection of Cancer |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMammography |
650 | 0 | 4 | _aMass Screening |
650 | 0 | 4 | _aUnited Kingdom |
700 | 1 | _aPharoah, Paul D P | |
773 | 0 |
_tJAMA oncology _gvol. 5 _gno. 3 _gp. 428-429 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamaoncol.2018.6504 _zAvailable from publisher's website |
999 |
_c29264055 _d29264055 |